rs756789619
Variant summary
Our verdict is Pathogenic. Variant got 18 ACMG points: 18P and 0B. PM1PM2PM5PP3_StrongPP5_Very_Strong
The ENST00000371712.4(INPP5E):c.1303C>T(p.Arg435Trp) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00000774 in 1,549,562 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Pathogenic (★★). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. R435Q) has been classified as Likely pathogenic.
Frequency
Consequence
ENST00000371712.4 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Pathogenic. Variant got 18 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
INPP5E | NM_019892.6 | c.1303C>T | p.Arg435Trp | missense_variant | 6/10 | ENST00000371712.4 | NP_063945.2 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
INPP5E | ENST00000371712.4 | c.1303C>T | p.Arg435Trp | missense_variant | 6/10 | 1 | NM_019892.6 | ENSP00000360777 | P1 | |
INPP5E | ENST00000676019.1 | c.1201C>T | p.Arg401Trp | missense_variant | 6/10 | ENSP00000501984 |
Frequencies
GnomAD3 genomes AF: 0.00000657 AC: 1AN: 152176Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.0000128 AC: 2AN: 156164Hom.: 0 AF XY: 0.00 AC XY: 0AN XY: 82292
GnomAD4 exome AF: 0.00000787 AC: 11AN: 1397386Hom.: 0 Cov.: 32 AF XY: 0.00000725 AC XY: 5AN XY: 689324
GnomAD4 genome AF: 0.00000657 AC: 1AN: 152176Hom.: 0 Cov.: 32 AF XY: 0.0000135 AC XY: 1AN XY: 74330
ClinVar
Submissions by phenotype
Joubert syndrome and related disorders Pathogenic:1
Likely pathogenic, no assertion criteria provided | clinical testing | Manipal Hospitals, Manipal Hospital | May 16, 2016 | Mutations in INPP5E cause Joubert syndrome: a clinically and genetically heterogenous group of disorders characterized by midbrain-hindbrain malformation and various associated ciliopathies. Features include the classic molar tooth sign on MRI, delayed psychomotor development, mental retardation, ataxia, hypotonia,ptosis,strabismus. - |
Joubert syndrome 1 Pathogenic:1
Pathogenic, criteria provided, single submitter | clinical testing | Center for Genomic Medicine, King Faisal Specialist Hospital and Research Center | Mar 29, 2024 | - - |
Familial aplasia of the vermis Pathogenic:1
Pathogenic, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Sep 19, 2023 | For these reasons, this variant has been classified as Pathogenic. This variant disrupts the p.Arg435 amino acid residue in INPP5E. Other variant(s) that disrupt this residue have been determined to be pathogenic (PMID: 23386033, 30202406). This suggests that this residue is clinically significant, and that variants that disrupt this residue are likely to be disease-causing. Advanced modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) performed at Invitae indicates that this missense variant is expected to disrupt INPP5E protein function. ClinVar contains an entry for this variant (Variation ID: 375472). This missense change has been observed in individual(s) with Joubert syndrome and related disorders (PMID: 29230161). The frequency data for this variant in the population databases is considered unreliable, as metrics indicate poor data quality at this position in the gnomAD database. This sequence change replaces arginine, which is basic and polar, with tryptophan, which is neutral and slightly polar, at codon 435 of the INPP5E protein (p.Arg435Trp). - |
INPP5E-related disorder Uncertain:1
Uncertain significance, no assertion criteria provided | clinical testing | PreventionGenetics, part of Exact Sciences | Jul 12, 2024 | The INPP5E c.1303C>T variant is predicted to result in the amino acid substitution p.Arg435Trp. This variant was reported in the homozygous state in an individual with Joubert syndrome with nephropathy (Shetty et al. 2017. PubMed ID: 29230161). This variant is reported in 0.0087% of alleles in individuals of East Asian descent in gnomAD. A different amino acid substitution at this position (p.Arg435Gln) has been reported in individuals with Joubert syndrome (Bielas et al. 2009. PubMed ID: 19668216; Alfares et al. 2018. PubMed ID: 30202406). Although we suspect that c.1303C>T (p.Arg435Trp) may be pathogenic, the clinical significance of this variant is uncertain due to the absence of conclusive functional and genetic evidence. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at